CollPlant Biotechnologies Ltd (CLGN)
6.33
-0.07
(-1.09%)
USD |
NASDAQ |
May 17, 16:00
6.33
0.00 (0.00%)
After-Hours: 20:00
CollPlant Biotechnologies Revenue (Quarterly): 0.299M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.299M |
| September 30, 2023 | 0.043M |
| June 30, 2023 | 10.18M |
| March 31, 2023 | 0.433M |
| December 31, 2022 | 0.058M |
| September 30, 2022 | 0.109M |
| June 30, 2022 | 0.066M |
| March 31, 2022 | 0.066M |
| December 31, 2021 | 0.31M |
| September 30, 2021 | 0.14M |
| June 30, 2021 | 0.691M |
| March 31, 2021 | 14.50M |
| December 31, 2020 | 0.557M |
| September 30, 2020 | 4.148M |
| June 30, 2020 | 0.823M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.609M |
| December 31, 2019 | 0.439M |
| September 30, 2019 | 0.679M |
| June 30, 2019 | 0.606M |
| March 31, 2019 | 0.594M |
| December 31, 2018 | 4.383M |
| September 30, 2018 | 0.224M |
| June 30, 2018 | 0.182M |
| March 31, 2018 | 0.225M |
| December 31, 2017 | 0.2601M |
| September 30, 2017 | 0.0745M |
| June 30, 2017 | 0.0576M |
| March 31, 2017 | 0.0695M |
| December 31, 2016 | 0.0514M |
| September 30, 2016 | 0.0245M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.043M
Minimum
Sep 2023
14.50M
Maximum
Mar 2021
1.830M
Average
0.439M
Median
Dec 2019
Revenue (Quarterly) Benchmarks
| Compugen Ltd | 33.46M |
| Pluri Inc | 0.071M |
| BioLine Rx Ltd | 4.80M |
| Can Fite Biofarma Ltd | 0.155M |
| BiomX Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.689M |
| Total Expenses (Quarterly) | 5.367M |
| EPS Diluted (Quarterly) | -0.42 |
| Enterprise Value | 45.95M |
| Gross Profit Margin (Quarterly) | -158.5% |
| Profit Margin (Quarterly) | -1.57K% |
| Earnings Yield | -10.09% |
| Normalized Earnings Yield | -10.09 |